«Arvelle Therapeutics»
Arvelle Therapeutics
Company
Arvelle Therapeutics is a biopharmaceutical company with the mission of bringing innovative solutions to patients suffering from CNS disorders.
Investors
Andera Partners
BPV Capital Management
F-Prime Capital
Forbion Capital Partners
H.I.G. BioHealth Partners
HBM Partners
KB Investment
Life Sciences Partners
NovaQuest
Novaquest Capital Management
Industry:
PharmTech
Headquarters:
Zug
Visit Website
info@arvelletx.com
Register and Claim Ownership
